Search Results - Langley, Jonathan
- Showing 1 - 6 results of 6
-
1
Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat popula... by Kuwana, Masataka, Blair, Christiana, Takahashi, Tomohiko, Langley, Jonathan, Coghlan, John G
Published 2020Text -
2
Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden by Lancaster, Lisa, Bonella, Francesco, Inoue, Yoshikazu, Cottin, Vincent, Siddall, James, Small, Mark, Langley, Jonathan
Published 2021Text -
3
-
4
Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis by Kreuter, Michael, Picker, Nils, Schwarzkopf, Larissa, Baumann, Severin, Cerani, Agustin, Postema, Roelien, Maywald, Ulf, Dittmar, Axel, Langley, Jonathan, Patel, Haridarshan
Published 2022Text -
5
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension by White, R. James, Vonk-Noordegraaf, Anton, Rosenkranz, Stephan, Oudiz, Ronald J., McLaughlin, Vallerie V., Hoeper, Marius M., Grünig, Ekkehard, Ghofrani, Hossein-Ardeschir, Chakinala, Murali M., Barberà, Joan A., Blair, Christiana, Langley, Jonathan, Frost, Adaani E.
Published 2019Text -
6
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION tr... by Coghlan, John Gerry, Galiè, Nazzareno, Barberà, Joan Albert, Frost, Adaani E, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M, Kuwana, Masataka, McLaughlin, Vallerie V, Peacock, Andrew J, Simonneau, Gérald, Vachiéry, Jean-Luc, Blair, Christiana, Gillies, Hunter, Miller, Karen L, Harris, Julia H N, Langley, Jonathan, Rubin, Lewis J
Published 2017Text